Le Lézard
Classified in: Health
Subjects: SVY, MRR

PLGA Market worth $321 Million by 2030 - Exclusive Report by MarketsandMarketstm


CHICAGO, March 27, 2024 /PRNewswire/ -- The report "PLGA Market  by Composition, Application (Medical, Non-Medical Applications), Processibility (Extrusion, Injection Molding), End-Use Industry (Healthcare, Biotech Firms, Medical Institutions, Packaging, Textile, Agriculture) - Global Forecast to 2030", is projected to reach USD 321 Million by 2030, at a CAGR of 16.6% from USD 125 Million in 2024.

MarketsandMarkets Logo

The PLGA market is driven by several factors, including technological advancements, shifting consumer behaviors, favorable economic conditions, expanding applications in various industries, and growing demand. The increasing use of PLGA in various end-use industries, such as healthcare, biotech firms, medical institutions, packaging, textile, and agriculture, is a significant driver for market growth.

Browse in-depth TOC on "PLGA Market".

180 ? Tables       
110 ? Figures
260 ? Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143024577

"Injection molding is projected to be the fastest growing processibility type of PLGA, in terms of value, during the forecast period."

Injection molding stands as a pivotal processibility type for PLGA (poly (lactic-co-glycolic acid)), offering businesses in various industries a versatile and efficient method for producing complex and precise polymer components. PLGA, renowned for its biodegradability, biocompatibility, and tunable properties, lends itself exceptionally well to the injection molding process. This manufacturing technique involves injecting molten PLGA resin into a mold cavity under high pressure, where it solidifies to form the desired shape. Injection molding offers several advantages for PLGA-based products, including high production efficiency, consistent part quality, and the ability to produce intricate geometries with tight tolerances. In industries such as healthcare, where PLGA finds extensive applications in medical devices, implants, and drug delivery systems, injection molding enables the mass production of customized and patient-specific components, facilitating cost-effective manufacturing and rapid product development cycles.

"Packaging is the fastest growing end-use industry of the PLGA, in terms of value."

Packaging stands as a pivotal end-use industry for PLGA (poly (lactic-co-glycolic acid), offering a promising avenue for sustainable and innovative solutions in the global packaging market. PLGA, renowned for its biodegradability, biocompatibility, and versatility, finds applications across various packaging sectors. In recent years, the packaging industry has witnessed a paradigm shift towards eco-friendly materials, driven by consumer demand for sustainable packaging solutions and tightening regulations governing plastic waste. PLGA emerges as a compelling alternative to traditional petroleum-based plastics, offering properties conducive to packaging applications such as films, coatings, and containers. Its ability to degrade into harmless byproducts under controlled conditions aligns with the circular economy principles, addressing concerns related to environmental pollution and resource depletion.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=143024577

"North America captures the largest share in the PLGA market during the forecast period, in terms of value."

The PLGA market in North America stands as a vibrant and evolving landscape within the realm of biodegradable polymers. Fueled by factors such as increasing demand for advanced drug delivery systems, growing investments in biomedical research, and stringent regulatory requirements promoting biocompatible materials, the market exhibits significant growth potential. North America, with its robust pharmaceutical and healthcare industries, serves as a key hub for PLGA adoption and innovation. Pharmaceutical companies are increasingly integrating PLGA into their product pipelines to develop controlled-release formulations for a wide array of therapeutics, including small molecules, biologics, and nucleic acid-based drugs. Moreover, advancements in PLGA manufacturing technologies and the emergence of novel applications beyond drug delivery, such as tissue engineering scaffolds and medical implants, further propel market expansion.

The key players profiled in the report include Evonik (Germany), Corbion NV (Netherlands), Ashland (US), Mitsui Chemicals (Japan), Jinan Digang Bioengineering Co., Ltd. (China), Merck (Germany), Akina, Inc. (US), Nomisma Healthcare Pvt. Ltd. (India), Bezwada Biomedical, LLC (US), CD Bioparticles (US).

Browse Adjacent Market: Green Bio Chemicals Market Research Reports & Consulting

Related Reports:

Biodegradable Plastics Market - GLOBAL FORECAST TO 2028

Bioresorbable Polymers Market - GLOBAL FORECAST TO 2027

About MarketsandMarketstm 

MarketsandMarketstm has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarketstm is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStoretm (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarketstm.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Aashish Mehra
MarketsandMarketstm INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insights:
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/plga.asp
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/plga-market.asp

Logo: https://mma.prnewswire.com/media/2297424/MarketsandMarkets_Logo.jpg  


These press releases may also interest you

at 02:15
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvantThis agreement represents a...

at 02:05
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") and Maze Therapeutics, Inc. (Head Office: South San Francisco, California, USA; Chief Executive Officer: Jason Coloma, Ph.D.;...

at 02:00
Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwardsProvides Novavax with cash and an equity investment totalling approximately $1.2 billion...

at 01:00
REGULATED INFORMATIONMay 10, 2024, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the "Company") Invitation to attend the annual and the extraordinary shareholders'...

at 00:16
WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, WGc-043. This landmark achievement marks the world's first approval of an EB virus-related mRNA...

at 00:00
SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), a new drug for polymer nanoparticle anticancer under clinical trial. SNB-101...



News published on and distributed by: